ERMEZA Trademark

Trademark Overview

On Tuesday, October 25, 2016, a trademark application was filed for ERMEZA with the United States Patent and Trademark Office. The USPTO has given the ERMEZA trademark a serial number of 87214828. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 4, 2019. This trademark is owned by Mylan Pharmaceuticals, Inc.. The ERMEZA trademark is filed in the Pharmaceutical Products category with the following description:

Hormone replacement therapy transdermals
ermeza

General Information

Serial Number87214828
Word MarkERMEZA
Filing DateTuesday, October 25, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 4, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2017

Trademark Statements

Goods and ServicesHormone replacement therapy transdermals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMylan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 15317

Trademark Events

Event DateEvent Description
Monday, November 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2019EXTENSION 4 GRANTED
Thursday, March 28, 2019EXTENSION 4 FILED
Wednesday, April 10, 2019NOTICE OF REVIVAL - E-MAILED
Wednesday, April 10, 2019EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, April 10, 2019PETITION TO REVIVE-GRANTED
Wednesday, April 10, 2019TEAS PETITION TO REVIVE RECEIVED
Friday, January 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2019EXTENSION 3 GRANTED
Friday, September 28, 2018EXTENSION 3 FILED
Thursday, January 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 1, 2018NOTICE OF REVIVAL - E-MAILED
Thursday, November 1, 2018EXTENSION RECEIVED WITH TEAS PETITION
Thursday, November 1, 2018PETITION TO REVIVE-GRANTED
Thursday, November 1, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, October 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 29, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 15, 2018EXTENSION 2 GRANTED
Thursday, March 15, 2018EXTENSION 2 FILED
Thursday, March 15, 2018TEAS EXTENSION RECEIVED
Friday, September 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2017EXTENSION 1 GRANTED
Wednesday, September 13, 2017EXTENSION 1 FILED
Wednesday, September 13, 2017TEAS EXTENSION RECEIVED
Tuesday, March 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 31, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 31, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 11, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 23, 2016ASSIGNED TO EXAMINER
Friday, October 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 28, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

ermeza transdermals therapy replacement hormone